Developing a laboratory animal model for perinatal endocrine disruption: The hamster chronicles

Experimental Biology and Medicine

Volumn 227, Issue 9, 2002, Pages 709-723

  Hendry III, William J ^a,b   Sheehan, Daniel M ^c   Khan, Shafiq A ^d   May, Jeffrey V ^a,b  

^a WICHITA STATE UNIVERSITY   (United States)

^b Women's Research Institute   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Cheek pouch; Diethylstilbestrol; Endocrine disruption; Estrogen; Transplantation

Indexed keywords

DIETHYLSTILBESTROL;

ANIMAL EXPERIMENT; DRUG EFFECT; ENDOCRINE DISEASE; EXPERIMENTAL ANIMAL; HAMSTER; NONHUMAN; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; SHORT SURVEY; TOXICITY TESTING;

ANIMALIA; CRICETINAE;

EID: 0036790443     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700904     Document Type: Short Survey

References (120)

1. Roy D, Palangat M, Chen C-W, Thomas RD, Colerangle J, Atkinson A, Yan Z-J. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J Toxicol Environ Health 50:1-29, 1997.
2. Vos AiCRG, Dybing E, Greim HA, Ladefoged O, Lambré C, Tarazona JV, Brandt I, Vethaak AD. Health effects of endocrinedisrupting chemical on wildlife, with special reference to the European situation. Crit Rev Toxicol 30:71-133, 2000.
3. Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetke KP, Hoffmann JL, Morrow MS, Rodier DJ, Schaeffer JE, Touart LW, Zeeman MG, Patel YM. Environmental endocrine disruption: An effects assessment and analysis. Environ Health Perspect 106(Suppl 1):11-56, 1998.
4. Danzo BJ. The effects of environmental hormones on reproduction. Cell Mol Life Sci 54:1249-1264, 1998.
5. DeRosa C, Richter P, Pohl H, Jones DE. Environmental exposures that affect the endocrine system: Public health implications. J Toxicol Environ Health B Crit Rev 1:3-26, 1998.
6. Colburn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384, 1993.
7. Jones LA, Hajek RA. Effects of estrogenic chemicals on development. Environ Health Perspect 103(Suppl 7):63-67, 1995.
8. Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395, 1993.
9. Daston GP, Gooch JW, Breslin WJ, Shuey DL, Nifikorov AI, Fico TA, Gorsuch JW. Environmental estrogens and reproductive health: A discussion of the human and environmental data. Reprod Toxicol 11:465-481, 1997.
10. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med 224:61-68, 2000.
11. Sheehan DM. Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: Initial results confirmed. Proc Soc Exp Biol Med 224:57-60, 2000.
12. Elswick BA, Miller FJ, Welsch F. Comments: Comments to the editor concerning the paper entitled "Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals" by C. Gupta. Exp Biol Med 226:74-75, 2001.
13. Gupta C. Comments: Response to the letter by B. Elswick et al. from the Chemical Industry Institute of Toxicology. Exp Biol Med 226:76-77, 2001.
14. Ashby J. Getting the problem of endocrine disruption into focus: The need for a pause for thought. Apmis 108:805-813, 2000.
15. Palmlund I. Exposure to a xenoestrogen before birth: The diethylstilbestrol experience. J Psychosom Obstet Gynecol 17:71-84, 1996.
16. Mittendorf R. Teratogen update: Carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology 51:435-445, 1995.
17. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878-881, 1971.
18. Marselos M, Tomatis L. Diethylstilbestrol: I, Pharmacology, toxicology and carcinogenicity in humans. Eur J Cancer 28A:1182-1189, 1992.
19. Marselos M, Tomatis L. Diethylstilbestrol: II, Pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer 29A:149-155, 1993.
20. Leavitt WW, Evans RW, Hendry WJ Iii. Etiology of DES-induced uterine tumors in the Syrian hamster. In: Leavitt WW, Ed. Hormones and Cancer. New York: Plenum Publishing Corporation, pp 63-86, 1982.
21. Hendry WJ III, Zheng X, Leavitt WW, Branham WS, Sheehan DM. Synthetic estrogen-mediated alterations in uterine cell fate. In: Tilly JL, Strauss JF III, Tenniswood M, Eds. Serono International Symposium on Cell Death in Reproductive Physiology. New York: Springer-Verlag, Inc., pp 272-291, 1997.
22. Herbst AL, Scully RE, Robboy SJ. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr 51:25-35, 1979.
23. Hendry WJ, III, Branham WS, Sheehan DM. Differential potency of a synthetic (diethylstilbestrol) and a natural (estradiol) estrogen as neonatal endocrine disruptors of the hamster uterine cervix. Biol Reprod 1998;58(Suppl 1):Abst. 49.
24. Hendry WJ III, DeBrot BL, Zheng X, Branham WS, Sheehan DM. Differential activity of diethylstilbestrol vs. estradiol as neonatal endocrine disruptors in the female hamster (Mesocricetus auratus) reproductive tract. Biol Reprod 61:91-100, 1999.
25. Khan SA, Ball RB, Hendry WJ Iii. Effects of neonatal administration of diethylstilbestrol in male hamsters: Disruption of reproductive function in adults after apparently normal pubertal development. Biol Reprod 58:137-142, 1998.
26. May JV, Rueda BR, Hendry WJ III. Physiological and morphological ramifications of neonatal diethylstilbestrol (DES) exposure in the hamster ovary. Biol Reprod 1998;58(Suppl 1):Abst. 57.
27. Newbold RR, Bullock BC, McLachlan JA. Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct. Biol Reprod 28:735-744, 1983.
28. Newbold RR, Bullock BC, McLachlan JA. Diverticulosis and salpingitis isthmica nodosa (SIN) of the fallopian tube. Am J Pathol 117:333-335, 1984.
29. Lutz BR, Fulton GP, Patt DI, Handler AH, Stevens DF. The cheek pouch of the hamster as a site for the transplantation of a methylcholanthrene-induced sarcoma. Cancer Res 11:64-69, 1951.
30. Saunders FJ. Effects of sex steroids and related compounds on pregnancy and on the development of the young. Physiol Rev 48:601-643, 1968.
31. Lisk RD. The estrous cycle. In: Siegel HI, Ed. The Hamster: Reproduction and Behavior. New York: Plenum Press, pp 23-51, 1985.
32. Siegal HI. Appendix-Characteristics of Mesocricetus auratus. In: Siegel HI, Ed. The Hamster: Reproduction and Behavior. New York: Plenum Press, 435-436, 1985.
33. Hendry WJ III, Leavitt WW. Altered morphogenesis of the immature hamster uterus following neonatal exposure to diethylstilbestrol. Differentiation 52:221-227, 1993.
34. Hendry WJ III, Zheng X, Leavitt WW, Branham WS, Sheehan DM. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri. Cancer Res 57:1903-1908, 1997.
35. Hendry WJ III, Leavitt WW. Binding and retention of estrogen in the uterus of hamsters treated neonatally with diethylstilbestrol. J Steroid Biochem 17:479-487, 1982.
36. Duby RT, McDaniel JW, Black DL. Homo-transplantation of the hamster uterus. Nature 205:720, 1965.
37. Hendry WJ III, Branham WS, Sheehan DM. The hamster cheek pouch as a convenient ectopic site for studies of uterine morphogenesis and endocrine responsiveness. Differentiation 51:49-54, 1992.
38. Zheng X, Hendry WJ III. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related protooncogenes (c-jun, c-fos, c-myc, bax, bcl-2 and bcl-x) in the hamster uterus. Cell Growth Differ 8:425-434, 1997.
39. Newbold RR, Hanson RB, Jefferson WN. Ontogeny of lactoferrin in the developing mouse uterus: A marker of early hormone response. Biol Reprod 56:1147-1157, 1997.
40. Tourville DR, Ogra SS, Lippes J, Tomasi JB. The human reproductive tract: Immunohistochemical localization of IgA, IgG, IgM, secretory "piece" and lactoferrin. Am J Obstet Gynecol 108:1102-1108, 1970.
41. Walmer DK, Padin CJ, Wrona MA, Healy BE, Bentley RC, Tsao M-S, Kohler MF, McLachlan JA, Gray KD. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res 55:1168-1175, 1995.
42. Mor G, Kohen F, Garcia-Velasco J, Nilsen J, Brown W, Song J, Naftolin F. Regulation of Fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen. J Steroid Biochem Mol Biol 73:185-194, 2000.
43. Nilsen J, Mor G, Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol 43:64-78, 2000.
44. Muramatsu M, Inoue S. Estrogen receptors: How do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun 270:1-10, 2000.
45. Wang H, Ericsson H, Sahlin L. Estrogen receptors α and β in the female reproductive tract of the rat during the estrous cycle. Biol Reprod 2000;63:1331-1340.
46. Matsuzaki S, Fukaya T, Suzuki T, Murakami T, Sasano H, Yajima A. Oestrogen receptor α and β mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 5:559-564, 1999.
47. Cunha GR. Role of epithelial-mesenchymal interactions in the development of hormonal responsiveness. In: Hochberg RB and Noftolin F, Eds. The New Biology of Steroid Hormones. New York: Raven Press, pp 301-310, 1990.
48. Cunha GR, Chung LWK, Shannon JM, Taguchi O, Fujii H. Hormone-induced morphogenesis and growth: Role of mesenchymalepithelial interactions. Rec Prog Horm Res 39:559-598, 1983.
49. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, Cunha GR. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A 94:6535-6540, 1997.
50. Olumi AF, Grossfield GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011, 1999.
51. Bigsby RM, Cooke PS, Cunha GR. A simple, efficient method for separating murine uterine epithelial and mesenchymal cells. Am J Physiol 251:E630-E636, 1986.
52. Kitajewski J, Sassoon D. The emergence of molecular gynecology: Homeobox and Wnt genes in the female reproducruve tract. BioEssays 22:902-910, 2000.
53. Mizejewski GJ. The phylogeny of alpha-fetoprotein in vertebrates: Survey of biochemical and physiological data. Crit Rev Eukaryot Gene Expr 5:281-316, 1995.
54. Savu L, Nunez EA, Jayle MF. High affinity testosterone, corticosterone and progesterone binding activities in pregnant hamster serum. Endocrinology 101:369-377, 1977.
55. Schatz R, Laugier C, Soto AM, Sonnenschein C. Alpha-fetoprotein serum levels and the development of estrogen-sensitive cell multiplication in the hamster uterus. Biol Reprod 28:1148-1154, 1983.
56. Sheehan DM, Young M. Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rat and human. Endocrinology 104:1442-1446, 1979.
57. Nelson KG, Sakai Y, Eitzman B, Steed T, McLachlan J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5:595-606, 1994.
58. Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, Mclachlan JA, Negishi M. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in the mouse uterus. Cancer Res 57:4356-4359, 1997.
59. Das SK, Taylor JA, Korach KS, Paria BC, Dey SK, Lubahn DB. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proc Natl Acad Sci U S A 94:12786-12791, 1997.
60. Jefferson WN, Padilla-Banks E, Newbold RR. Lactoferrin is an estrogen responsive protein in the uterus of mice and rats. Reprod Toxicol 14:103-110, 2000.
61. Markey CM, Michaelson CL, Veson EC, Sonnenschein C, Soto AM. The mouse uterotrophic assay: A reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect 109:55-60, 2001.
62. Newbold RR, Jefferson WN, Padilla-Banks E, Walker VR, Pena DS. Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol 15:245-252, 2001.
63. Haney AF, Newbold RR, McLachlan JA. Prenatal diethylstilbestrol exposure in the mouse: Effects on ovarian histology and steroidogenesis in vitro. Biol Reprod 30:471-478, 1984.
64. Iguchi T, Fukazawa Y, Uesugi Y, Takasugi N. Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol Reprod 43:478-484, 1990.
65. Iguchi T, Takasugi N, Bern HA, Mills KT. Frequent occurrence of polyovular follicles in ovaries of mice exposed neonatally to diethylstilbestrol. Teratology 34:29-35, 1986.
66. McLachlan JA, Newbold RR, Shah HC, Hogan MD, Dixon RL. Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil Steril 38:364-371, 1982.
67. Khan SA, Chen L, Johnson H, Hendry WJ. Disruption of male reproductive function in adult hamsters after neonatal diethylstilbestrol treatment may be due to altered androgen action. In: Program of the 82nd Annual Meeting of the Endocrine Society, Toronto, Canada, 2000. Abst. #1387.
68. Diehl P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol 73:1-10, 2000.
69. Horbelt DV, Parmley TH, Roberts DK, Walker NJ. Stromal-epithelial communications in hyperplastic human endometrium. Am J Obstet Gynecol 170:1061-1072, 1994.
70. Horbelt DV, Roberts DK, Parmley TH, Walker NJ. Ultrastructural cell-to-cell interactions in hyperplastic endometrial stroma. Gynecol Oncol 55:433-442, 1994.
71. Parmley TH, Roberts DK, Walker NJ, Horbelt DV. Intercellular contacts between stromal cells in the normal human endometrium throughout the menstrual cycle. Hum Pathol 21:1063-1066, 1990.
72. Roberts DK, Walker NJ, Lavia LA. Ultrastructural evidence of stromal/epithelial interactions in the human endometrial cycle. Am J Obstet Gynecol 158:854-861, 1988.
73. Gilloteaux J, Paul RJ, Steggles AW. Upper genital tract abnormalities in the Syrian hamster as a result of in utero exposure to diethylstilbestrol. I. Uterine cystadenomatous papilloma and hypoplasia. Virchows Arch 398:163-183, 1982.
74. Medlock KL, Sheehan DM, Nelson CJ, Branham WS. Effects of postnatal DES treatment on uterine growth, development, and estrogen receptor levels. J Steroid Biochem 29:527-532, 1988.
75. Medlock KL, Branham WS, Sheehan DM. Long-term effects of postnatal exposure to diethylstilbestrol on uterine estrogen receptor and growth. J Steroid Biochem Mol Biol 42:23-28, 1992.
76. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40:3988-3999, 1980.
77. Newbold RR, McLachlan JA. Vaginal adenosis, and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res 42:2003-2011, 1982.
78. Ostrander PL, Mills KT, Bern HA. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J Natl Cancer Inst 74:121-135, 1985.
79. Hertig AT, Sommers SC. Genesis of endometrial carcinoma. I. Study of prior biopsies. Cancer 2:43-50, 1949.
80. Hertig AT, Sommers SC, Vengloff H. Genesis of endometrial carcinoma. III. Carcinoma in situ. Cancer 2:964-971, 1949.
81. Koshiyama M, Konishi I, Fujii S. Review: Pathology, hormonal aspects, and molecular genetics of the two types of endometrial cancer. Cancer J 11:277-283, 1998.
82. Maier DB, Newbold RR, McLachlan JA. Prenatal diethylstilbestrol exposure alters murine uterine responses to prepubertal estrogen stimulation. Endocrinology 116:1878-1886, 1985.
83. Nickerson JA. Nuclear dreams: The malignant alteration of nuclear architecture. J Cell Biochem 70:172-180, 1998.
84. Ghadially FN. Ultrastructural Pathology of the Cell and Matrix. London: Butterworths, 1988.
85. Clark JH, Hardin JW, Padykula HA, Cardasis CA. Role of estrogen receptor binding and transcriptional activity in the stimulation of hyperestrogenism and nuclear bodies. Proc Natl Acad Sci USA 75:2781-2784, 1978.
86. Padykula HA, Fitzgerald M, Clark JH, Hardin JW. Nuclear bodies as structural indicators of estrogenic stimulation in uterine luminal epithelial cells. Anat Rec 201:679-696, 1981.
87. Brasch K, Ochs RL. Nuclear bodies (NBs): A newly "rediscovered" organelle. Exp Cell Res 202:211-223, 1992.
88. Matera AG. Nuclear bodies: Subdomains of the interchromatin space. Trends Cell Biol 9:302-309, 1999.
89. Bloch DB, Chiche J-D, Orth D, De La Monte SM, Rosenzweig A, Bloch KD. Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol 19:4423-4430, 1999.
90. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175-4179, 1999.
91. Zweyer M, Riederer B, Ochs RL, Fackelmayer FO, Kohwi-Shigematsu T, Bareggi R, Narducci P, Martelli AM. Association of nuclear matrix proteins with granular and threaded nuclear bodies in cell lines undergoing apoptosis. Exp Cell Res 230:325-336, 1997.
92. Tchernitchin A. Fine structure of rat uterine eosinophils and the possible role of eosinophils in the mechanism of estrogen action. J Steroid Biochem 4:277-282, 1973.
93. Jeziorska M, Salmonsen LA, Wooley DE. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 53:312-320, 1995.
94. Tchemitchin A, Tchernitchin X, Galand P. New concepts on the action of oestrogens in the uterus and the role of the eosinophil receptor system. Differentiation 5:145-150, 1976.
95. Perez MC, Furth EE, Matzumura PD, Lyttle CR. Role of eosinophils in uterine responses to estrogen. Biol Reprod 54:249-254, 1996.
96. Chiang T, McBride J, Chou MY, Nishimura I, Wong DTW. Molecular cloning of the complementary DNA coding for the hamster TGF-α mature peptide. Carcinogenesis 12:529-532, 1991.
97. Elovic A, Galli SJ, Weller P, Chang ALC, Chiang T, Chou MY, Donoff RB, Gallagher GT, Matossian K, McBride J, Tsai M, Todd R, Wong DTW. Production of transforming growth factor alpha by hamster eosinophils. Am J Pathol 137:1425-1434, 1990.
98. Ghiabi M, Gallagher GT, Wong DTW. Eosinophils, tissue eosinophilia, and eosinophil-derived transforming growth factor α in hamster oral carcinogenesis. Cancer Res 52:389-393, 1992.
99. Martinez-Hernandes A, Amenta PS. The basement membrane in pathology. Lab Invest 6:636-677, 1983.
100. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9:701-706, 1997.
101. Pullan S, Wilson J, Metcalfe A, Edwards GM, Goberdhan N, Tilly J, Hickman JA, Dive C, Streuli CH. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 109:631-642, 1996.
102. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327-332, 1993.
103. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 79:189-192, 1994.
104. Bellamy COC, Malcomson RDG, Harrison DJ, Wyllie AH. Cell death in health and disease: The biology and regulation of apoptosis. Semin Cancer Biol 6:3-16, 1995.
105. Metcalfe A, Streuli C. Epithelial apoptosis. BioEssays 19:711-720, 1997.
106. Bulletti C, Galassi A, Jasonni VM, Martinelli G, Tabanelli S, Flamigni C. Basement membrane components in normal, hyperplastic, and neoplastic endometrium. Cancer 62:142-149, 1988.
107. Faber M, Wewer UM, Berthelsen JG, Liotta LA, Albrechtsen R. Laminin production by human endometrial stromal cells relates to the cyclic and pathologic state of the endometrium. Am J Pathol 124:384-398, 1986.
108. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 11:95-103, 1992.
109. Hendry WJ III, Rueda BR, May JV. Consequences to ovarian morphology of neonatal exposure to endocrine disruptors. In: Program of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, 1999. Abst. #P3-240.
110. Bigsby R, Chapin RE, Daston GP, Davis BJ, Gorski J, Gray LE, Howdeshell KL, Zoeller RT, vom Saal FS. Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect 107(suppl 4):613-617, 1999.
111. Kaiser J. Endocrine disrupters: Panel cautiously confirms low-dose effects. Science 290:695-697, 2000.
112. Caldwell BV, Pawling RS, Wright PA. Reestablishment of ovarian periodicity after transplantation to the Syrian hamster cheek pouch. Proc Soc Exp Biol Med 123:551-553, 1966.
113. Titus-Ernstoff L, Hatch EE, Hoover RN, Palmer J, Greenberg ER, Ricker W, Kaufman R, Noller K, Herbst AL, Colton T, Hartge P. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer 84:126-133, 2001.
114. Hatch EE, Herbst AL, Hoover RN, Noller KL, Adam E, Kaufman RH, Palmer JR, Titus-Ernstoff L, Hyer M, Hartge P, Robboy SJ. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control 12:837-845, 2001.
115. Swan SH. Intrauterine exposure to diethylstilbestrol: long-term effects in humans. Apmis 108:793-804, 2000.
116. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 74:357-364, 2000.
117. Flototto T, Djahansouzi S, Glaser M, Hanstein B, Niederacher D, Brumm C, Beckmann MW. Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm Metab Res 33:451-457, 2001.
118. Stephens C, Budge RC, Carryer J. What is this thing called hormone replacement therapy? Discursive construction of medication in situated practice. Qual Health Res 12:347-359, 2002.
119. Yang C, Chen S. Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor. Cancer Res 59:4519-4524, 1999.
120. Zhang Z, Teng CT. Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275:20837-20846, 2000.